Versant Venture Management »

Jade Biosciences shares owned by Versant Venture Management

Quarter-by-quarter ownership of Jade Biosciences (JBIO) shares owned by Versant Venture Management from 13F filings

Historical chart of Versant Venture Management investment in Jade Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Jade Biosciences held by Versant Venture Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Jade Biosciences by Versant Venture Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $13M 1.5M 8.63
2025-06-30 $15M 1.5M 9.99

More positions owned by Versant Venture Management

Lenz Therapeutics Common Stock (LENZ)
Monte Rosa Therapeutics Common Stock (GLUE)
Jade Biosciences Common Stock (JBIO)
CRISPR Therapeutics Common Shares (CRSP)
Skye Bioscience Common Stock (SKYE)
Contineum Therapeutics Common Stock (CTNM)
Repare Therapeutics Common Stock (RPTX)
Tempest Therapeutics Common Stock
Adverum Biotechnologies Common Stock

View all positions for Versant Venture Management

Top funds holding Jade Biosciences

FMR
Fairmount Funds Management
VR Adviser
Deep Track Capital
BlackRock
Vanguard Group
Versant Venture Management
Rtw Investments
Frazier Life Sciences Management
Driehaus Capital Management
Avidity Partners Management
RA Capital Management
Standard Life Aberdeen
Soleus Capital Management
Geode Capital Management

View all funds holding Jade Biosciences